Incidence and mortality of multiple myeloma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016
Abstract Background The accurate information about burden of multiple myeloma (MM) at national and provincial level remains unknown in China. Methods Following the general analytical strategy used in GBD 2016, the age-, sex-, and province-specific incidence and mortality in China were analyzed. Tren...
Main Authors: | Jiangmei Liu, Weiping Liu, Lan Mi, Xinying Zeng, Cai Cai, Jun Ma, Lijun Wang, Union for China Lymphoma Investigators of the Chinese Society of Clinical Oncology, Union for China Leukemia Investigators of the Chinese Society of Clinical Oncology |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13045-019-0807-5 |
Similar Items
-
Burden of lymphoma in China, 2006–2016: an analysis of the Global Burden of Disease Study 2016
by: Weiping Liu, et al.
Published: (2019-11-01) -
Mortality of lymphoma and myeloma in China, 2004–2017: an observational study
by: Weiping Liu, et al.
Published: (2019-03-01) -
Chinese consensus on pancreatic cancer diagnosis and treatment (2014 version)
by: The Chinese Society of Clinical Oncology Pancreatic Cancer Expert Committee
Published: (2014-12-01) -
Multiple myeloma in Armenia during the period 2006–2018: facts and discussion
by: Narine Ghazaryan, et al.
Published: (2021-08-01) -
Chinese Expert Consensus on Next Generation Sequencing Diagnosis
for Non-small Cell Lung Cancer (2020 Edition)
by: Chinese Society of Clinical Oncology, Expert Committee on Non-small Cell Lung Cancer
Published: (2020-09-01)